Eric H. Bent

687 total citations
10 papers, 525 citations indexed

About

Eric H. Bent is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eric H. Bent has authored 10 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eric H. Bent's work include Immune cells in cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). Eric H. Bent is often cited by papers focused on Immune cells in cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). Eric H. Bent collaborates with scholars based in United States, France and Germany. Eric H. Bent's co-authors include Michael T. Hemann, Luke A. Gilbert, Daniel R. Goulet, Julia Fröse, Chenyu Jiao, Olivier Lequin, Gérard Chassaing, C. Lacombe, Nicole Goasdoué and Isabelle Correia and has published in prestigious journals such as Cell, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Eric H. Bent

10 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric H. Bent United States 6 252 196 165 78 45 10 525
Chongkui Sun China 13 337 1.3× 125 0.6× 192 1.2× 57 0.7× 124 2.8× 16 621
Christie Fanton United States 11 198 0.8× 267 1.4× 288 1.7× 38 0.5× 36 0.8× 26 587
Lance C. Bridges United States 13 311 1.2× 98 0.5× 162 1.0× 47 0.6× 80 1.8× 22 620
Mariano F. Zacarías Fluck Spain 8 176 0.7× 186 0.9× 236 1.4× 64 0.8× 87 1.9× 15 463
Shihe Hou United States 13 235 0.9× 141 0.7× 212 1.3× 81 1.0× 131 2.9× 25 624
Rama Jasty United States 11 372 1.5× 142 0.7× 141 0.9× 33 0.4× 82 1.8× 18 583
Liangsheng Fan China 17 325 1.3× 133 0.7× 232 1.4× 17 0.2× 163 3.6× 29 591
Jonathan Keller United States 6 239 0.9× 328 1.7× 94 0.6× 89 1.1× 29 0.6× 8 608
Dominic J. Corkill United Kingdom 9 116 0.5× 147 0.8× 80 0.5× 69 0.9× 115 2.6× 14 405
Beate Alinger Austria 19 490 1.9× 75 0.4× 192 1.2× 33 0.4× 152 3.4× 23 734

Countries citing papers authored by Eric H. Bent

Since Specialization
Citations

This map shows the geographic impact of Eric H. Bent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric H. Bent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric H. Bent more than expected).

Fields of papers citing papers by Eric H. Bent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric H. Bent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric H. Bent. The network helps show where Eric H. Bent may publish in the future.

Co-authorship network of co-authors of Eric H. Bent

This figure shows the co-authorship network connecting the top 25 collaborators of Eric H. Bent. A scholar is included among the top collaborators of Eric H. Bent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric H. Bent. Eric H. Bent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bent, Eric H. & Michael J. Morris. (2025). Prostate Cancer Radioligand Therapy: PSMA and Beyond, Current Landscape and Future Directions. Current Oncology Reports. 27(10). 1170–1184. 1 indexed citations
2.
Whiting, Karissa, Aditi Gupta, Eric H. Bent, et al.. (2025). Treatment patterns and clinical outcomes with platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in patients with metastatic urothelial carcinoma.. Journal of Clinical Oncology. 43(16_suppl). 4573–4573. 1 indexed citations
3.
Mahmood, Umair, Mai Anh Huynh, Joseph H. Killoran, et al.. (2022). Retrospective Review of Outcomes After Radiation Therapy for Oligoprogressive Disease on Immune Checkpoint Blockade. International Journal of Radiation Oncology*Biology*Physics. 114(4). 666–675. 10 indexed citations
4.
Bent, Eric H., et al.. (2021). Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy. Nature Communications. 12(1). 6218–6218. 104 indexed citations
5.
Bent, Eric H., Eric Wehrenberg-Klee, Eugene J. Koay, Lipika Goyal, & Jennifer Y. Wo. (2021). Integration of Systemic and Liver-Directed Therapies for Locally Advanced Hepatocellular Cancer: Harnessing Potential Synergy for New Therapeutic Horizons. Journal of the National Comprehensive Cancer Network. 19(5). 567–576. 7 indexed citations
6.
Bent, Eric H., et al.. (2020). Microenvironmental IL-6 Inhibits the Efficacy of Immunogenic Therapy by Suppressing Anti-Cancer Immunity. International Journal of Radiation Oncology*Biology*Physics. 108(3). S111–S111. 1 indexed citations
7.
Bent, Eric H., Luke A. Gilbert, & Michael T. Hemann. (2016). A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses. Genes & Development. 30(16). 1811–1821. 137 indexed citations
8.
Pallasch, Christian P., Ilya Leskov, Christian Braun, et al.. (2014). Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy. Cell. 156(3). 590–602. 130 indexed citations
9.
10.
Walrant, Astrid, Isabelle Correia, Chenyu Jiao, et al.. (2010). Different membrane behaviour and cellular uptake of three basic arginine-rich peptides. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1808(1). 382–393. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chongkui Sun Breakdown of academic impact, for papers by Christie Fanton Breakdown of academic impact, for papers by Lance C. Bridges Breakdown of academic impact, for papers by Mariano F. Zacarías Fluck Breakdown of academic impact, for papers by Shihe Hou Breakdown of academic impact, for papers by Rama Jasty Breakdown of academic impact, for papers by Liangsheng Fan Breakdown of academic impact, for papers by Jonathan Keller Breakdown of academic impact, for papers by Dominic J. Corkill Breakdown of academic impact, for papers by Beate Alinger
Rankless by CCL
2026